Zhejiang Hisun Pharmaceutical Stock Forecast for 2023 - 2025 - 2030
Updated on 04/28/2024
Stock Rating
11
Price Target
¥8.30
Consensus
Neutral
Upside
5.46%
Analysts
0
Stock Rating
11
Upside
5.46%
Analysts
0
Price Target
¥8.30
Zhejiang Hisun Pharmaceutical Stock Forecast and Price Target
In recent months, notable analysts have provided yearlong price targets for Zhejiang Hisun Pharmaceutical, with the average target coming in at ¥8.30. If it were to be achieved, this would result in a potential upside of approximately 5.46 percent from the most recent closing price in February, 2024. The high end is ¥8.30, and the low is ¥8.30. If you're looking for Zhejiang Hisun Pharmaceutical (600267) stock information, you might also want to check out BASF (XTRA:BAS).
¥8.30
5.46% Upside
Hold
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BAS Stock Forecast | BASF | Outperform |
12
|
48.83€ | Buy/Sell | 49.50€ | 14.68% |
| DSFIR Stock Forecast | DSM-Firmenich | Outperform |
18
|
105.30€ | Buy/Sell | 114.60€ | 13.96% |
| 4151 Stock Forecast | Kyowa Kirin | Outperform |
18
|
¥2.63k | Buy/Sell | ¥3.06k | 14.07% |
| 002001 Stock Forecast | Zhejiang NHU | Outperform |
17
|
¥18.35 | Buy/Sell | ¥20.23 | 4.63% |
| 600299 Stock Forecast | Bluestar Adisseo | Outperform |
18
|
¥9.27 | Buy/Sell | ¥9.81 | 12.19% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 600521 Stock Forecast | Zhejiang Huahai Pharmaceutical | Outperform |
14
|
¥16.05 | Buy/Sell | ¥19.80 | -2.80% |
| 300702 Stock Forecast | Zhejiang Tianyu Pharmaceutical | Buy |
16
|
¥18.11 | Buy/Sell | ¥26.00 | 43.57% |
| URGN Stock Forecast | UroGen Pharma | Outperform |
6
|
$14.15 | Buy/Sell | $39.00 | 189.75% |
.jpg)
Site Navigation
.jpg)